H1N1 vaccine a tough sell to pregnant women
Los Angeles Times, October 23, 2009
As the H1N1 influenza vaccine trickles into clinics and pharmacies over the next few weeks, public health officials and doctors desperately hope that pregnant women will be at the front of the line for the shot. Past influenza pandemics have proved that they're at increased risk for severe complications—and they appear to be even more vulnerable to this new flu strain. But pregnant women have a well-established antipathy toward vaccinations, with only 15% getting the flu vaccine in any given year, compared with 30% of the general population.
Most Viewed
Most Emailed
- CMS Reveals Central Line Infection Rates, Finally
- Keeping Readmission Rates Low with Treatment Guidelines
- 5010 Logjam Means No Pay for Physicians
- Medicare Physician Payment Rule Factors in GPCI
- Leading Change is Tough from the Back of a Limo
- Feds Release Final Rules on Health Plan Language
- Getting to the Heart of Cardiology Alignment
- Engineering a High-Performance Emergency Department
- UnitedHealth will tie doctors' payments to quality of care
- Parkland Keeping Consultant's Analysis Under Wraps

